Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Study Group: Cubicin Prescribers (US)

Council Members in this Study Group: 180

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Contact Gerson Lehrman Group to survey or consult with members of this Study Group

Leading institutions connect with members of this Study Group through GLG

Leading Experts in this Study Group

Alan Patterson, MD

Obstetrician and Gynecologist
ALAN B PATTERSON MD, PA
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Alan Patterson, MD, is an Obstetrician and Gynecologist at Alan B Patterson MD, a private practice in Florida, since May 1991. Dr. Patterson was on the teaching staff at Methodist Hospital, Indianapolis, where he wrote many protocols for the residency program. In the past few years, Dr. Patterson has...

Marina Raikhel, MD, Director, TORRANCE MEMORIAL MEDICAL CENTERMarina Raikhel, MD

Director
TORRANCE MEMORIAL MEDICAL CENTER
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Marina Raikhel, MD, is an active family practitioner with a particular interest in primary care and ob/gyn focus. She has expertise in the treatment of a wide variety of internal medicine conditions, with special focus on diabetes, hypertension, obesity, anxiety, and depression. She is Director ofTorrance...

Donald Graham, MD

Department Chair of Infectious Diseases
SPRINGFIELD CLINIC LLP
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Donald Graham, MD, is Chairman of the Department of Infectious Diseases at the Springfield Clinic in Illinois. He is also Clinical Professor of Medicine at Southern Illinois University School of Medicine. Dr. Graham serves as Medical Advisor of the Sangamon County Department of Public Health. He has...

Jeffrey Weinberg, Director of Clinical Research - Dermatology, ST LUKE'S-ROOSEVELT HOSPITAL CENTERJeffrey Weinberg

Director of Clinical Research - Dermatology
ST LUKE'S-ROOSEVELT HOSPITAL CENTER
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Jeffrey Weinberg, MD, is Director of the Clinical Research Center in the Department of Dermatology at St. Luke's-Roosevelt Hospital Center and Beth Israel Medical Center, both of which are part of the Continuum Health Partners hospital system in New York. He is also an Assistant Clinical Professorin...

Lowell Young, MD

Director
CALIFORNIA PACIFIC MEDICAL CENTER
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Lowell Young, MD, is Director of the Kuzell Institute for Arthritis & Infectious Diseases at the California Pacific Medical Center Research Institute in San Francisco. Dr. Young is also Attending Physician and Clinical Professor at the University of California’s San Francisco Medical Center. He is...

Forrest Rubenstein, MD

Cardiac, Thoracic and Vascular Surgeon
Rubenstein Cardiovascular and Thoracic Surgery
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Forrest Rubenstein, MD, FACS, is a Cardiac, Thoracic and Vascular Surgeon in private practice. Dr. Rubenstein is board certified in General, Cardiovascular and Thoracic Surgery. He has experience in cardiac, thoracic and vascular surgery, aortic surgery, trauma, endovascular surgery, drug eluting stents,...

Peter Bornstein, MD, Partner and Consultant in Infectious Diseases, St. Paul Infectious Disease Associates, LtdPeter Bornstein, MD

Partner and Consultant in Infectious Diseases
St. Paul Infectious Disease Associates, Ltd
What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Peter Bornstein, MD, is a Partner and Consultant in Infectious Diseases at St. Paul Infectious Disease Associates, Ltd., in St. Paul, Minnesota. Dr. Bornstein is the Chief of Staff at St. John's Hospital, Maplewood, MN. He spends most of his time seeing critically ill and chronically ill patients.Dr....

GLG NewsSM Analyses by this Study Group's Leading Experts (?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Which Combination of Drugs for Influenza?

October 29, 2009

Triple-combo Drug Shows Promise Against Antiviral Resistant H1N1 | www.medicalnewstoday.com

All 3 of these drugs are approved for use. Rimantadine is usually interchangeable with amantadine and is less toxic. Ribavirin can have very nasty side effects. Not clear from the report is whether the company is marketing a use of all 3 drugs or whether they are packaging the 3 in one pill. It isa...

The good news is that these drugs are already approved

October 28, 2009

Peter Bornstein, MD, Partner and Consultant in Infectious Diseases, St. Paul Infectious Disease Associates, Ltd

Triple-combo Drug Shows Promise Against Antiviral Resistant H1N1 | www.medicalnewstoday.com

Adamas has a proprietary mixture of three drugs: amantadine, oseltamivir and ribavirin to treat antiviral resistant strains of novel H1N1 Influenza A.

Starpharma gets US patent for use of VivaGel for protection against STIs

September 29, 2009

Jeffrey Weinberg, Director of Clinical Research - Dermatology, ST LUKE'S-ROOSEVELT HOSPITAL CENTER

Starpharma gets US patent for use of VivaGel for protection against STIs | www.pharmabiz.com

Starpharma's lead product, is a vaginal microbicide gel under development for the prevention of sexually transmitted infections (STIs), including genital herpes and HIV infection. The VivaGel® product concept is designed to offer a safe, convenient and affordable means for women to protect themselves...

Stelara new Option for Psoriasis

September 26, 2009

Jeffrey Weinberg, Director of Clinical Research - Dermatology, ST LUKE'S-ROOSEVELT HOSPITAL CENTER

Stelara Approved to Treat Moderate to Severe Plaque Psoriasis in Adults | www.webmd.com

The FDA approved Stelara based on three studies of 2,266 patients who either got shots of Stelara or a placebo. Patients who got Stelara were more likely to achieve the studies' benchmark for reduction in psoriasis.In a news release, the FDA notes that because Stelara reduces the immune system's ability...

Earlier Treatment Just Makes Sense

July 19, 2009

AIDS treatment should start sooner, study finds | news.yahoo.com

These data will help justify earlier treatment of patients infected with HIV, before damage to the immune system occurs.

View All GLG News by members of this Study Group

Members in this Study Group include these company types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic

Members in this Study Group often have these job titles:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • Physician - Division Head
  • Partner

GLG Live Meetings with this Study Group's Leading Experts (?)

Upcoming Seminars

Leading Experts in Cubicin Prescribers (US) Study Group have not participated in any upcoming seminars.

View All GLG Live Meetings in Healthcare

GLG Webcasts

Leading Experts in Cubicin Prescribers (US) have not participated in any GLG webcasts.

View All GLG Webcasts in Healthcare